Your browser doesn't support javascript.
loading
Effect of dipeptidyl peptidase-4 inhibitors on complement activation.
Hoffmann-Petersen, Ingeborg T; Holt, Charlotte B; Jensen, Lisbeth; Hage, Camilla; Mellbin, Linda G; Thiel, Steffen; Hansen, Troels K; Østergaard, Jakob A.
Afiliação
  • Hoffmann-Petersen IT; Department of Internal Medicine, Regional Hospital of Northern Jutland, Hjørring, Denmark.
  • Holt CB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Jensen L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Hage C; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Mellbin LG; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Thiel S; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Hansen TK; Cardiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Østergaard JA; Cardiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
Diabetes Metab Res Rev ; 37(3): e3385, 2021 03.
Article em En | MEDLINE | ID: mdl-32662092

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação do Complemento / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação do Complemento / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Idioma: En Ano de publicação: 2021 Tipo de documento: Article